SWOG S0905: A randomized phase II study of cediranib versus placebo in combination with cisplatin and pemetrexed in chemonaive patients with malignant pleural mesothelioma
| العنوان: | SWOG S0905: A randomized phase II study of cediranib versus placebo in combination with cisplatin and pemetrexed in chemonaive patients with malignant pleural mesothelioma |
|---|---|
| المؤلفون: | Nicholas J. Vogelzang, Mary W. Redman, James Gilbert Hueftle, Charles Lu, Shirish M. Gadgeel, Jieling Miao, Ignacio I. Wistuba, Frank V. Fossella, Mario R. Velasco, John V. Heymach, Anne S. Tsao, David R. Gandara, Brandy Box-Noriega, Karen Kelly |
| المصدر: | Journal of Clinical Oncology. 36:8514-8514 |
| بيانات النشر: | American Society of Clinical Oncology (ASCO), 2018. |
| سنة النشر: | 2018 |
| مصطلحات موضوعية: | Cisplatin, Oncology, Cancer Research, medicine.medical_specialty, business.industry, Pleural mesothelioma, Phases of clinical research, respiratory system, Placebo, respiratory tract diseases, Cediranib, 03 medical and health sciences, 0302 clinical medicine, Pemetrexed, 030228 respiratory system, 030220 oncology & carcinogenesis, Internal medicine, Medicine, business, medicine.drug |
| الوصف: | 8514Background: Anti-angiogenic inhibitors combined with cisplatin-pemetrexed (CP) have shown efficacy in unresectable malignant pleural mesothelioma (MPM). Cediranib, a vascular endothelial growth... |
| تدمد: | 1527-7755 0732-183X |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_________::4254684a288cae39303bd71bb10e2f4bTest https://doi.org/10.1200/jco.2018.36.15_suppl.8514Test |
| رقم الانضمام: | edsair.doi...........4254684a288cae39303bd71bb10e2f4b |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15277755 0732183X |
|---|